Speaker illustration

Professor Christian Funck-Brentano

Pitie Salpetriere APHP University Hospital, Paris (France)

Member of:

European Society of Cardiology

Christian Funck-Brentano is Professor of Medicine and Clinical Pharmacology at Sorbonne Université and Pitié-Salpêtrière University Hospital in Paris. He is Head of the Department of Pharmacology and of the APHP/INSERM Clinical Investigation Center at Pitié-Salpêtrière. After completing his training in Cardiology in Paris he was a Merck International Fellow in Clinical Pharmacology at Vanderbilt University, Nashville, TN. under the mentorship of Raymond L. Woosley and Dan M. Roden. He then returned to Paris and has been working in Assistance-Publique Hôpitaux de Paris since then. Dr Funck-Brentano's researches are in the field of cardiotoxicity of cardiovascular and non-cardiovascular drugs, notably drug-induced proarrhythmia, polymorphisms of drug metabolism and drug-drug interactions. He has been involved in phase I, II and III clinical trials (adjudication and safety committees) and in ESC Guidelines activities. Dr Funck-Brentano has published >250 publications.

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt?

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session type: Official Joint Session


Crunching the numbers: how to critically analyse a clinical trial

Event: ESC Congress 2017

Topic: Miscellaneous

Session type: Special Session


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb